C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 121 filers reported holding C4 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,799 | +65.3% | 16,021 | +144.3% | 0.00% | – |
Q2 2023 | $18,032 | -75.8% | 6,557 | -72.4% | 0.00% | – |
Q1 2023 | $74,522 | -99.4% | 23,733 | -95.3% | 0.00% | -100.0% |
Q1 2022 | $12,224,000 | +36.8% | 503,888 | +151.9% | 0.05% | +25.6% |
Q3 2021 | $8,936,000 | +42.6% | 200,000 | +20.8% | 0.04% | +39.3% |
Q2 2021 | $6,266,000 | – | 165,600 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |